Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 29, No. 1, 2009   

Free Abstract     Article (Fulltext)     Article (PDF 275 KB)     

Original Report: Patient-Oriented, Translational Research

Extremes of Glycemic Control (HbA1c) Increase Hospitalization Risk in Diabetic Hemodialysis Patients in the USA
M.E. Williamsa, E. Lacson, Jr.b, M. Tengb, R.M. Hakimb, J.M. Lazarusb

aRenal Unit, Joslin Diabetes Center, Boston, Mass., and
bFresenius Medical Care, Lexington, Mass., USA

Address of Corresponding Author

Am J Nephrol 2009;29:54-61 (DOI: 10.1159/000151276)


 goto top of page Key Words

  • End-stage renal disease, hospitalization
  • Diabetes mellitus
  • Glycemic control

 goto top of page Abstract

Background/Aims: Because the relation between glycemic control and clinical outcomes found in the general diabetic population has not been established in diabetic hemodialysis patients, we evaluated the association between glycemic control and hospitalization risk. Methods: We performed a primary retrospective data analysis on 23,829 hemodialysis patients with diabetes mellitus. Hemoglobin A1c at baseline and hospitalization events over the subsequent 12 months were analyzed and logistic regression models constructed for unadjusted, case mix-adjusted and case mix plus lab- adjusted data. Models were also constructed for cardiovascular, vascular access and sepsis hospitalizations. Results: Eighty percent had type 2 DM, 5% type 1 and 14% not specified. The groups had similar mean HbA1c levels, 6.8 ± 1.6%. Among all patients, the mean HbA1c values were >7% in 35%. The odds ratio of hospitalizations grouped by baseline HbA1c was significant at extremes of <5% and >11%. Similar relationships were evident for the subset of type 2 DM and in the analysis for hospitalizations due to sepsis. Conclusion: Extremely high and low HbA1c values are associated with hospitalization risk in diabetic hemodialysis patients. Prospective studies are needed to determine whether meeting recommended HbA1c targets might improve outcomes without posing additional risks in this population.

Copyright © 2008 S. Karger AG, Basel


 goto top of page Author Contacts

M.E. Williams
Renal Unit, Joslin Diabetes Center, 1 Joslin Place
Boston, MA (USA)
Tel. +1 617 732 2477, Fax +1 617 732 2467, E-Mail mark.williams@joslin.harvard.edu


 goto top of page Article Information

Received: April 30, 2008
Accepted: May 12, 2008
Published online: August 8, 2008
Number of Print Pages : 8
Number of Figures : 3, Number of Tables : 1, Number of References : 46

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18689979)
Download Citation
Cited In



This journal is part of the third subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel